TUFANO, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 5.920
EU - Europa 3.798
NA - Nord America 3.439
SA - Sud America 822
AF - Africa 173
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 14.160
Nazione #
SG - Singapore 3.321
US - Stati Uniti d'America 3.269
RU - Federazione Russa 1.947
CN - Cina 1.287
BR - Brasile 658
DE - Germania 526
HK - Hong Kong 514
IT - Italia 510
VN - Vietnam 381
NL - Olanda 147
GB - Regno Unito 121
FI - Finlandia 115
KR - Corea 104
CA - Canada 86
IN - India 86
FR - Francia 74
CI - Costa d'Avorio 70
IE - Irlanda 62
UA - Ucraina 62
ES - Italia 57
AR - Argentina 55
BD - Bangladesh 48
MX - Messico 48
AT - Austria 42
ZA - Sudafrica 35
PL - Polonia 34
ID - Indonesia 28
EC - Ecuador 27
SE - Svezia 24
IQ - Iraq 23
JP - Giappone 22
CL - Cile 17
VE - Venezuela 17
CO - Colombia 16
PY - Paraguay 14
MA - Marocco 13
CH - Svizzera 11
BE - Belgio 10
AE - Emirati Arabi Uniti 9
PE - Perù 9
SA - Arabia Saudita 9
TR - Turchia 9
BG - Bulgaria 8
DZ - Algeria 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AZ - Azerbaigian 6
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
PK - Pakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
CZ - Repubblica Ceca 5
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
NP - Nepal 5
TN - Tunisia 5
UY - Uruguay 5
UZ - Uzbekistan 5
BO - Bolivia 4
BW - Botswana 4
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
LV - Lettonia 4
NI - Nicaragua 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
CD - Congo 3
DK - Danimarca 3
GE - Georgia 3
HN - Honduras 3
LB - Libano 3
MD - Moldavia 3
PH - Filippine 3
PT - Portogallo 3
YE - Yemen 3
AO - Angola 2
AU - Australia 2
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
ET - Etiopia 2
HT - Haiti 2
IR - Iran 2
KZ - Kazakistan 2
MG - Madagascar 2
MK - Macedonia 2
ML - Mali 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TZ - Tanzania 2
Totale 14.132
Città #
Singapore 1.556
Hefei 571
Hong Kong 514
Moscow 462
Ashburn 309
Santa Clara 308
Beijing 290
Chandler 213
Naples 147
Ho Chi Minh City 145
Los Angeles 137
Millbury 124
Amsterdam 120
Seoul 104
Hanoi 86
Redondo Beach 80
São Paulo 75
San Jose 74
Buffalo 71
Boston 68
Princeton 67
Munich 60
New York 59
The Dalles 59
Nuremberg 56
Nanjing 49
Dallas 48
Lawrence 41
Krefeld 38
Chicago 35
Denver 34
London 34
Milan 34
Seattle 34
Des Moines 33
Wilmington 33
Boardman 32
Ottawa 32
Chennai 30
Frankfurt am Main 27
Jacksonville 27
Orem 27
Turku 27
Brooklyn 26
Mexico City 25
Warsaw 25
Rome 24
Montreal 22
Napoli 22
Tokyo 21
Helsinki 20
Stockholm 20
Rio de Janeiro 19
Atlanta 18
Castellón 18
Da Nang 18
Poplar 18
Vienna 18
Düsseldorf 17
Belo Horizonte 16
Mykolayiv 16
Norwalk 16
Toronto 16
Haiphong 15
Johannesburg 15
Kronberg 15
Manchester 15
Phoenix 15
Brasília 14
Nanchang 14
Ann Arbor 13
Baghdad 13
Hebei 13
Jiaxing 13
Kochi 13
Changsha 12
Curitiba 12
Dhaka 12
Falkenstein 12
Tettnang 12
Woodbridge 12
Basel 11
Campinas 11
New Delhi 11
Dublin 10
Lappeenranta 10
Leawood 10
Santiago 10
Tianjin 10
Bologna 9
Council Bluffs 9
Hải Dương 9
Redwood City 9
San Francisco 9
Asunción 8
Buenos Aires 8
Guayaquil 8
Houston 8
Lauterbourg 8
Nocera Inferiore 8
Totale 7.181
Nome #
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 207
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry 207
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 164
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 152
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 146
Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia 131
Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis 127
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 123
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 121
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation 118
Challenging report of cardiopulmonary bypass in 16th week pregnant patient with endoventricular mass 118
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 114
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 113
Use of oral anti-Xa inhibitor in prosthetic mechanical aortic valve with warfarin hypersensitivity due to the FIX p.(Ala37Thr) pro peptide variant: case report and literature review. 113
Fondaparinux in the initial and long-term treatment of venous thromboembolism 112
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 111
Inferior Vena Cava Agenesis and Deep Vein Thrombosis in the Young: A Review of the Literature and Local Experience 110
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review 110
Plasma homocysteine and its determinants in diabetic retinopathy 110
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 110
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism 109
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 109
Acquired haemophilia a in the elderly: case reports. 107
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 105
Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review 103
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 103
Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus 103
Oxidative stress and plateletactivation in homozygous homocystinuria 103
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 103
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis 103
Plasma homocysteine and microvascular complications in type 1 diabetes. 102
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 102
The role of cardiovascular ultrasound in diagnosis and management of pulmonary embolism 102
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 102
Corrigendum: The new Italian registry of infantile thrombosis (RITI): a reflection on its journey, challenges and pitfalls 101
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry 101
Preventing postsurgical venous thromboembolism: pharmacological approaches 101
A Rare Case of Tricuspid Valve Libman-Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome 100
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 100
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 99
Predisposing factors in patients with early-onset cerebral vein thrombosis 98
The new Italian registry of infantile thrombosis (RITI): A reflection on its journey, challenges and pitfalls. 98
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. 98
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 95
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis: First report from the italian registry of pediatric thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili) 95
The infectious burden in atherothrombosis. 95
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 95
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 94
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 94
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE 93
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 93
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry 93
HELLP syndrome and its relation with the antiphospholipid syndrome. 93
The hla variant rs6903608 is associated with disease onset and relapse of immune-mediated thrombotic thrombocytopenic purpura in caucasians 93
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy 92
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura 92
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 92
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 91
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 91
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 90
Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry 89
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs 89
Venous thromboembolism: which patients are truly at risk? 89
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 89
Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism 88
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 88
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 88
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies 88
The impact of risk-adjusted heparin regimens on the outcome of patients with covid-19 infection. A prospective cohort study 88
Non-O blood group as a risk factor for cerebral vein thrombosis 87
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project 87
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 87
Aspirin for preventing the recurrence of venous thromboembolism. 87
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 87
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 86
The thromboembolic risk in giant cell arteritis: A critical review of the literature 85
Atrial Fibrillation, Cancer and Echocardiography 85
Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry 83
Pharmacokinetic Studies, Assessing the Efficiency of FVIII/VWF Concentrates and Intravenous Human Immunoglobulin, Revealed the Etiopathogenesis of Acquired von Willebrand Disease in Patient With MGUS 83
Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis 83
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism 82
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 82
Acquired Inhibitors of coagulation factors: Part I-acquired hemophilia a 82
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 81
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 80
A novel mutation in the fibrinogen γ-chain gene c.952G>T, p. (Gly318Cys) leading to hypo dysfibrinogenemia 80
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 80
Arterial Thrombosis in Cancer Patients: An Update 80
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 80
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism 79
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism 76
DVT Management and Outcome Trends, 2001 to 2014 76
Management of ischemic heart disease in hemophiliac patients: new challenges from a case report and review of the literature 74
Italian intersociety consensus on DOAC use in internal medicine 74
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism 73
Venous thromboembolism in patients immobilised at home 73
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry. 71
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism 70
Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre 70
Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. 70
Totale 9.819
Categoria #
all - tutte 49.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 6 1 10 3 8 0
2021/2022668 1 1 3 0 3 4 19 10 132 85 134 276
2022/2023895 145 66 13 29 57 65 0 173 178 106 52 11
2023/2024841 29 105 144 49 34 14 11 120 58 22 159 96
2024/20254.968 236 323 24 67 139 281 484 309 503 490 1.668 444
2025/20266.464 1.053 972 1.062 1.142 1.704 433 98 0 0 0 0 0
Totale 14.484